| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/12/2006 | US20060009451 10-[4-(3-Piperidin-1-yl-propoxy)-phenyl]-6,7,8,9-tetrahydro-5H-1,4,10a-triaza-cyclohepta[f]indene; 8-[4-(3-Pyrrolidin-1-yl-propoxy)-phenyl]-6,7-dihydro-5H-1,4,8a-triaza-s-indacene; 9-{4-[3-(2-Methyl-pyrrolidin-1-yl)-propoxy]-phenyl}-5,6,7,8-tetrahydro-pyrazolo[5,1-b]quinazoline |
| 01/12/2006 | US20060009450 Use and methods of use of etanercept and other TNF binding biologics to improve human cognitive function |
| 01/12/2006 | US20060009449 Naphthaline derivatives as H3 inverse agonists |
| 01/12/2006 | US20060009448 Metabolites of 4-(3,4-dichloro-phenyl)-2-[2-(4-methyl-piperazin-1-yl)-benzylidene]thiomorpholin-3-one |
| 01/12/2006 | US20060009447 Pharmaceutical compositions comprising midazolam in a high concentration |
| 01/12/2006 | US20060009446 New compounds |
| 01/12/2006 | US20060009445 Tumor-inhibiting anellated azepinone derivatives |
| 01/12/2006 | US20060009444 Method for decreasing depression by inhibiting the activity of n-type calcium channel |
| 01/12/2006 | US20060009443 Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 01/12/2006 | US20060009442 Process for producing carbapenem compound for oral administration |
| 01/12/2006 | US20060009441 Human trace amine associated receptors |
| 01/12/2006 | US20060009440 Heterocyclic compounds and antitumor drugs containing the same as the active ingredient |
| 01/12/2006 | US20060009439 Novel physiologically active substances |
| 01/12/2006 | US20060009438 Administering steroid (such as estrogen) containing hydrophobic substitutions such as adamantane ring; therapy for Alzheimer's, Parkinson's, huntington's disease; multiple sclerosis; amyotrophic lateral sclerosis; strokes; antiischemic agents |
| 01/12/2006 | US20060009437 A medicament containing formoterol or formoterol fumarate and/or mometasone furoate, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease; inhalable form in an atomizable composition or in a dry powder |
| 01/12/2006 | US20060009436 11 beta -Fluoro-7 alpha -{5-[methyl(7,7,8,8,9,9,9-heptafluorononyl)amino]pentyl}-17 alpha -methylestra-1,3,5(10)-triene-3,17 beta -diol N-oxide; antiestrogen compound whose metabolism can be controlled; alveolar macrophages do not build up; oral administration |
| 01/12/2006 | US20060009435 Synthesis and powder preparation of fluticasone propionate |
| 01/12/2006 | US20060009434 e.g. 3-Hydroxy-2-phenylethinyl-estra-1,3,5(10)-trien-17-one 19; anticarcinogenic, antitumor agent; hormone-dependent tumor disease of a male/female reproductive gland or endometriosis; estrogen-dependent diseases |
| 01/12/2006 | US20060009433 Neuroprotective spirostenol pharmaceutical compositions |
| 01/12/2006 | US20060009432 Use of neurosteroids to treat neuropathic pain |
| 01/12/2006 | US20060009431 Nitrosated and nitrosylated compounds, compositions and methods use |
| 01/12/2006 | US20060009430 Composition for the prevention and treatment of the detrimental effects of dihydrotestosterone |
| 01/12/2006 | US20060009429 Antiandrogen oligonucleotides usable for the treatment of dermatological androgen-related disorders relating to androgen metabolism, their pharmaceutical compositions, their uses and treatment method |
| 01/12/2006 | US20060009428 Cyclic progestin regimens and kits |
| 01/12/2006 | US20060009427 4-(2-Cyano-cyclohexyloxy)-2-trifluoromethyl-benzonitrlle, a salt, or an isomer;selective androgen receptor modulators; decrease excess sebum secretions; stimulafnts of hair growth at higher rates of cosmetically acceptable hair growth in patients with alopecia; acne; skin disorders; prostate cancer |
| 01/12/2006 | US20060009426 Pharmaceutical compositions comprising calcitriol and a clobetasol propionate |
| 01/12/2006 | US20060009425 Oral formulations of paricalcitol |
| 01/12/2006 | US20060009424 Nasaleaze |
| 01/12/2006 | US20060009423 Phosphonate-phosphate and diphosphonate apolipoprotein e modulators |
| 01/12/2006 | US20060009422 Antibiotics incorporating borinic acid complexes; (bis(3-chloro-4-methylphenyl)boryloxy)(3-hydroxypyridin-2-yl)methanone; Antiinflammatory drugs; enhanced stability |
| 01/12/2006 | US20060009421 Three-branched sugar-chain asparagine derivatives, the sugar-chain asparagines, the sugar chains, and processes for producing these |
| 01/12/2006 | US20060009420 Aqueous formulations of (2-hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4-trifluorobutane-1-sulfonate |
| 01/12/2006 | US20060009419 Therapy-enhancing glucan |
| 01/12/2006 | US20060009418 Use of the quinazoline derivative zd6474 combined with gemcitabine and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability |
| 01/12/2006 | US20060009417 Contacting (4S,2R,3R,5R)-2-(6-chloropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol with a protected (2-hydroxy) cyclopentylamine compound having a protecting group on the 2-hydroxy moiety;contacting=with thionyl chloride in the presence of a second base;contacting with base, removing protecting group |
| 01/12/2006 | US20060009416 Vitamin B6, pyridinoline, 3-hydroxypyridine, or an N-alkyl-3-hydroxypyridine; sunscreen agents |
| 01/12/2006 | US20060009415 Corneal epithelial migration promoter |
| 01/12/2006 | US20060009414 Protecting a muscarinic acetylcholine receptor in patient; prevent tissue damage, increasing the efficacy of a therapeutic agent |
| 01/12/2006 | US20060009413 Methods and compositions for protecting or treating muscarinic receptors through administration of pyrophosphate analog in subjects exposed to toxic or carcinogenic metals or metal ions |
| 01/12/2006 | US20060009409 Double-stranded oligonucleotides |
| 01/12/2006 | US20060009407 Administering arginine, lysine; cardiovascular disorder therapy |
| 01/12/2006 | US20060009405 Bispecific Oligonucleotide for the Treatment of CNS Malignancies |
| 01/12/2006 | US20060009403 Dna demethylase antisense and chemotherapy combination |
| 01/12/2006 | US20060009402 Engineered RNA precursors encoded in plasmids and/or other vectors; simple, low cost technique utilizing DNA molecule production; host cells, transgenes |
| 01/12/2006 | US20060009401 Method for treatment and prevention of herpes zoster by topical application |
| 01/12/2006 | US20060009400 have an inhibiting effect on the sodium-dependent glucose cotransporter SGLT; treatment of metabolic disorders |
| 01/12/2006 | US20060009399 Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors |
| 01/12/2006 | US20060009398 Compositions comprising gelatin-glycine and carotenoids |
| 01/12/2006 | US20060009387 Apo-2 ligand/trail formulations |
| 01/12/2006 | US20060009385 Multiple-variable dose regimen for treating TNFalpha-related disorders |
| 01/12/2006 | US20060008917 Diagnostic methods for determining susceptibility to convulsive conditions |
| 01/12/2006 | US20060008910 stable nucleic acid-lipid particles (SNALP) |
| 01/12/2006 | US20060008862 treating a disease associated with reduced activity of hexosaminidase (Tay Sachs disease and Sandhoff disease) by administering a compound selected from pyrimethamine and probucol |
| 01/12/2006 | US20060008835 PNA monomer and precursor |
| 01/12/2006 | US20060008804 Marker genes |
| 01/12/2006 | US20060008797 Peptide that that binds to microglial receptors; may be conjugated to a carrier molecule that increases transport across the blood-brain barrier; treating neurological effects of cerebral ischemia or cerebral inflammation |
| 01/12/2006 | US20060008796 Methods for screening cellular proliferation using isotope labels |
| 01/12/2006 | US20060008574 Galactosyl isomalt, method for production and use thereof |
| 01/12/2006 | US20060008530 Tissue matrix system |
| 01/12/2006 | US20060008529 Use of additive sites to control nitric oxide release from nitric oxide donors contained within polymers |
| 01/12/2006 | US20060008526 Controlled release metformin compositions |
| 01/12/2006 | US20060008525 Controlled release metformin compositions |
| 01/12/2006 | US20060008524 Controlled release metformin compositions |
| 01/12/2006 | US20060008523 Controlled release metformin compositions |
| 01/12/2006 | US20060008520 Delayed release formulations of 6-mercaptopurine |
| 01/12/2006 | US20060008516 Gilsonite derived pharmaceutical delivery compositions and methods: cosmetic applications |
| 01/12/2006 | US20060008515 Anti-microbial chitosan composition for textile products |
| 01/12/2006 | US20060008512 Composition and methods for improved animal performance |
| 01/12/2006 | US20060008510 Composition and methods for improved avian performance |
| 01/12/2006 | US20060008509 synergistic efficacy; polar lipid supplement, a soluble fiber, and a nutricine such as threonine |
| 01/12/2006 | US20060008508 Dry powder; administering htrough feeding tube |
| 01/12/2006 | US20060008505 Product |
| 01/12/2006 | US20060008502 Method and composition for bone growth |
| 01/12/2006 | US20060008501 prosthesis, shunt, catheter or local drug delivery device with coating of a biocompatible chemically hardened oil or fat containing a therapeutic agent; e.g. partially hydrogenated oil or fat |
| 01/12/2006 | US20060008487 Method of skin care and/or treatment using thioredoxin |
| 01/12/2006 | US20060008481 Topically applying bactericide gentian violet (methylrosaniline) and a suppository base; soothing and healing effect |
| 01/12/2006 | US20060008459 Combination therapy of respiratory diseases using antibodies |
| 01/12/2006 | US20060008443 Ophthalmic compositions for lubricating eyes and methods for making and using same |
| 01/12/2006 | US20060008436 Heterocyclic compound for stimulating or inducing the growth of the hair or eyelashes and/or slowing down their loss, composition comprising it and its uses |
| 01/12/2006 | US20060008425 Antiplaque oral composition containing enzymes and cyclodextrins |
| 01/12/2006 | US20060008421 Pharmaceutical combination |
| 01/12/2006 | US20060008420 Nasal spray formulation and method |
| 01/12/2006 | US20060006033 Images affixed to luggage wheels easy access to closed luggage |
| 01/12/2006 | US20060005741 mixture as additive in paint; reducing the attachment of shellfish and algae to ship bottoms and marine structures |
| 01/12/2006 | DE4216644B4 Liposomen enthaltende Arzneimittel Liposomes containing drugs |
| 01/12/2006 | DE19961182B4 Galactomannan-Oligosaccharide und Verfahren zu deren Herstellung sowie deren Verwendung Galactomannan oligosaccharides and processes for their preparation and their use |
| 01/12/2006 | DE19925211B4 Kit zur Herstellung einer Formulierung von Paclitaxel Kit for preparing a formulation of paclitaxel |
| 01/12/2006 | DE10393906T5 Verfahren zur Erhöhung der Bioverfügbarkeit von Alendronat oder einem anderen Bisphosphonat durch Verabreichen einer Vordosis eines Vitamin D-Derivats A method for increasing the bioavailability of alendronate or another bisphosphonate by administering a predose of a vitamin D-derivative |
| 01/12/2006 | DE102004030987A1 Ortho-substituierte (3-Hydroxyphenyl)-essigsäure-benzyliden-hydrazide Ortho-substituted (3-hydroxyphenyl) -acetic acid benzylidene-hydrazide |
| 01/12/2006 | DE102004030880A1 Methode zur Behandlung von Diabetes Method for the treatment of diabetes |
| 01/12/2006 | DE102004030502A1 Neue Imidazole und Triazole, deren Herstellung und Verwendung als Arzneimittel New imidazoles and triazoles, their preparation and use as medicaments |
| 01/12/2006 | DE102004030305A1 Preventing or treating neurodegenerative or dementia diseases characterized by molecular pathology of microtubuli-associated tau protein comprises administering a K252a derivative |
| 01/12/2006 | DE102004030099A1 Gesättigte und ungesättigte 3-Pyridyl-benzocycloalkylmethyl-amine als Serotonin- und/oder Noradrenalin-Reuptake-Hemmer und/oder µ-Opioidrezeptor-Modulatoren Saturated and unsaturated 3-pyridyl-benzocycloalkylmethyl-amines as serotonin and / or norepinephrine reuptake inhibitor and / or μ-opioid receptor modulators |
| 01/12/2006 | DE102004028940A1 Oral zerfallende pharmazeutische Zusammensetzung, die Risperidon enthält Orally disintegrating pharmaceutical composition containing risperidone |
| 01/12/2006 | CA2628005A1 Oral antimicrobial pharmaceutical compositions |
| 01/12/2006 | CA2607208A1 Compounds, pharmaceutical compositions and methods for inhibiting hiv infectivity |
| 01/12/2006 | CA2575048A1 Synthesis of polyoxygenated nitrogen systems, comprising reactions between enamines of 1,3-dioxan-5-ones and nitroolefins |
| 01/12/2006 | CA2573193A1 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 01/12/2006 | CA2572990A1 Use of substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines in the treatment of nausea and vomiting |
| 01/12/2006 | CA2572874A1 Urea derivative |